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Abstract 
This paper reviews information about gallbladder disease, diabetes, and Native Americans to 
evaluate if such individuals are at increased risk of developing gallbladder disease in comparison 
to their non-Native American counterparts who do not have diabetes. Gallbladder disease is 
defined as cholecystitis, cholelithiasis, and cholecystectomy, unless otherwise noted. The case 
report evaluates a 47-year old obese female who presents with mid-to-right upper quadrant pain 
radiating to the back with a fever, tachycardia, and nausea after eating a meal the night prior to 
evaluation. The patient has a history of diabetes and a family history of gallstones. There is a 
higher incidence of both diabetes and gallbladder disease in the Native American population. 
However, no direct correlation between the two diagnoses within the Native American 
population was found in the literature. This paper also reviews the risk factors of developing 
diabetes, factors which increase the likelihood of developing gallbladder disease, and 
preventative measures for patient education. The information presented is important for 
preventative care and education for patients who have the risk factors for gallbladder disease, 
obesity, and diabetes. 
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Background 
 Gallbladder disease is a common occurrence in patients in Western countries. The case 
report that started this literature review is a middle-aged adult female presenting with acute 
abdominal pain to the right upper quadrant with fever, nausea, vomiting, and tachycardia. The 
diagnostic findings of an elevated white blood cell count, elevated liver function tests, positive 
Murphy’s sign, and an ultrasound led to the conclusion of acute cholecystitis. 
The literature was reviewed to determine if certain factors increase a patient’s risk of 
developing gallbladder disease, particularly patients who have type 2 diabetes and are of Native 
American ancestry. According to Dunphy et al., (2015), gallstones were found in 75% of 
American Indian women over the age of 25. Native Americans are also 2.5 times more likely to 
develop diabetes in comparison to the non-Hispanic white population of the same age (Fretts et 
al., 2014). The purpose of this review is to determine if there is an increased risk of gallbladder 
disease as a result of having diabetes and being of Native American ancestry.  
There are many factors that can increase or decrease the risk of certain diseases. Some of 
these factors cannot be changed, such as age, gender, race, or ethnicity. Other factors can be 
changed or altered, such as the patient’s weight, lifestyle habits (smoking, alcohol use), diet, and 
activity level. Dunphy et al. (2015) lists risk factors associated with cholelithiasis as being of the 
female gender, obesity, pregnancy, increased age, rapid weight loss, diabetes mellitus, sickle cell 
anemia, spinal cord injury, cystic fibrosis, ileal disease, hemolytic diseases, cirrhosis, biliary 
stasis, and chronic biliary infections. Many of these risk factors can also increase a patient’s risk 
of developing type 2 diabetes. Measures can be taken to prevent both gallbladder disease and 
diabetes. Healthcare providers have an important role in educating patients to make the best 
choices to prevent disease, thus optimizing their health.  
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 Gallbladder disease, or cholecystitis, is the inflammation of gallbladder, which is 
commonly the result of gallstones (cholelithiasis) in the bile duct created over time due to the 
stasis of cholesterol (Dunphy et al., 2015). Gallstones are commonly made of cholesterol in 75-
80% of cases (Di Ciaula, Wang, & Portincasa, 2018). Inflammation of the bile duct due to 
obstructing gallstones results in gastrointestinal upset, pain to epigastric region or right upper 
quadrant (RUQ) of the abdomen, nausea, and vomiting (Dunphy et al., 2015). These symptoms 
occur usually after consuming a high-fat meal. As inflammation worsens, the pain can become 
localized to the RUQ or can radiate to right flank or shoulder. Ultrasound is the gold standard for 
imaging and for diagnosis of gallbladder disease (Dunphy et al., 2015).  
Case Report 
The patient is a 47-year old fair-skinned female, presenting with a complaint of constant 
pain to the middle and right upper abdomen after eating dinner last night. Pain rated 8-9 out of 
10 on the pain scale, lasting for the past 12 hours.  She complained of nausea, vomiting, and 
possible fever. The right upper quadrant pain radiates to right side of back and up to right 
shoulder; worse with movement or when lying down. Pain is described as dull in nature. Emesis 
was yellow in color after vomiting up meal. She vomited three times with symptoms starting 
after she ate dinner the night prior to presenting for evaluation. The patient reports that she has 
had abdominal pain like this episode before, but the pain had resolved after a couple of hours. 
The patient complains of fever, nausea, and vomiting; denies diarrhea or constipation. 
She denies hematuria, blood in stool, or change in stool pattern. The patient denies any change in 
appetite, weight loss, or gain. A review of systems was otherwise unremarkable.  
The patient has history of obesity, type 2 diabetes, and hypertension. She has no known 
allergies. Her current medications are metformin 1000mg daily and lisinopril 20mg daily. This 
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patient self-reports diet as comfort food, eating food that the children usually like, such as mac 
and cheese, and spaghetti and meatballs. She has no past surgical history. The patient has a 
family medical history of stroke, resulting in death of her father; her mother had gallstones. This 
patient is a nonsmoker, drinks 1-2 glasses of wine most nights, and does not use recreational 
drugs. She is married and lives with her husband and two children.  
Assessment 
The physical assessment includes vital signs with a temperature of 99.5 F, pulse 102 
bpm, respirations 20 bpm, blood pressure 116/70, and a body mass index (BMI) of 30.2 kg/m2. 
Upon assessment, this patient did appear to be in acute distress and discomfort, guarding 
abdomen. Bowel sounds were present in all four quadrants, tender to palpation with a positive 
Murphy’s sign. The remainder of physical assessment was within normal limits.  
Laboratory tests were conducted, finding an elevated white blood cell count, elevated 
alkaline phosphatase, and elevated total and direct bilirubin. These abnormal values are 
consistent with acute gallbladder disease. A comprehensive metabolic panel was ordered with 
amylase and lipase to rule out pancreatitis and a troponin to rule out myocardial infarction, which 
were all within normal limits as well. An abdominal ultrasound was ordered, since it is the 
standard imaging used to diagnose gallbladder disease and can also rule out pancreatitis, 
appendicitis, and a peptic ulcer (Dunphy et al., 2015).  
Treatment of gallbladder disease is dependent on the severity of patient presentation and  
surgical risk, based on the patient’s medical history. Symptomatic treatment includes rehydration 
with intravenous fluids, antiemetics for nausea, pain management, insertion of a nasogastric tube 
for persistent vomiting, and ingesting nothing by mouth. An early surgical intervention is the 
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treatment of choice for acute gallbladder disease to prevent serious complications, such as 
empyema and perforation (Dunphy et al., 2015).  
Literature Review 
 The patient in the case report meets several of the risk factors for gallbladder disease, 
being female, having diabetes, being obese, consuming an unhealthy diet, having a sedentary 
lifestyle, and being older in age. The literature was reviewed to define a possible correlation in a 
patient’s risk of developing gallbladder disease, particularly patients who have type 2 diabetes 
and are of Native American ancestry. 
Gallbladder Disease 
Aune and Vatten (2016) found that diabetes increases the likelihood of gallbladder 
disease by 56%. There is also a strong correlation with dyslipidemia, obesity, metabolic 
syndrome, and insulin resistance. The study done by Zheng (2018)  evaluates the mortality of 
patients with gallbladder disease. Zheng (2018) found an increased prevalence of gallbladder 
disease in patients of Native American and Hispanic ancestry. These patients also had an 
increased mortality of gallbladder disease with cardiovascular disease and cancer.  
Women are twice as likely to have gallbladder disease and have a cholecystectomy, 
which has been attributed to hormonal factors due to the gap between genders as age progresses 
(Figueiredo, Haiman, Porcel, Buxbaum, Stram, Tambe, & Setiawan, 2017). Figueiredo et al. 
(2017) believe that hormones in females increase the risk of developing gallbladder disease. 
Women who become pregnant and develop gallbladder disease, is thought to be due to the 
insulin resistance and hyperinsulinemia during pregnancy (Figueiredo et al., 2017).  
In pregnant patients, it is recommended to initially treat as supportive care with pain 
control with narcotics because NSAIDS are not recommended during pregnancy due to the 
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antiplatelet effects. Surgical intervention is reserved for patients with intractable pain or 
obstruction due to gallstones. Preferred surgery is laparoscopic and has been done successfully in 
all trimesters of pregnancy (Abraham, Rivero, Erlikh, Griffith, & Kondamudi, 2014). During 
pregnancy, gallbladder disease can be treated with laparscopic surgery.  
Dyakiv-Koreiba (2018) found a correlation of increased incidence of gallbladder disease 
in women with combined pathologies, including diabetes. She also found hepatomegaly in 51% 
of the patients based on their ultrasound, stating that diabetes provokes the development of bile 
duct disease (Dyakiv-Koreiba, 2018). This information was very intriguing as it suggests that 
gallbladder disease is a possible consequence of diabetes. Patients with diabetes are more at risk 
for cardiovascular disease.  
Native American Population 
Diabetes is prevalent within the Native American population as they are 2.5 times more 
likely to have diabetes compared to white non-Hispanic people in the same age group (Fretts et 
al., 2014). This number is astounding in such a small population. In 2009, the prevalence of 
diabetes was nearly 31% in the Native American population with the median age of onset 39 
years of age (Fretts et al., 2014). Diabetes prevalence is increasing, affecting one out of three 
Native Ameicans.  
Although high mortality rates for patients with gallbladder disease are low, the rates are 
increased within Native American patients. A group of surgeons in New Mexico evaluated a 
sample of patients of Native American ancestry that had less than optimal post-surgical results 
due to an increased risk of bile duct injury during laparoscopic cholecystectomies (Greenbaum, 
Alkahalili, Li Luo, Rajput, Nir, Luo, 2017). This condition is hypothesized to be resulted from 
genetics affecting biliary anatomy, late access to care due to cultural norms, and the rurality of 
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the state and Native American communities (Greenbaum, Alkhalili, Li Luo, Rajput, Nir, & Luo, 
(2017). This common occurrence for increased complications of health conditions does not 
normally have high mortality rates in populations of lower socioeconomic status, leading to late 
care or absence of follow up after hospitalization.   
Diabetes and Gallbladder Disease 
Diabetes is one of the most important risk factors related to the development of 
gallstones, which is the most important risk factor for gallbladder cancer. Gallstone formation is 
similar to the metabolic abnormalities seen with obesity, metabolic syndrome, insulin resistance, 
and type 2 diabetes (Di Ciaula, 2018). With the rates of diabetes in the Native American 
population, the number of expected patients with gallbladder disease is shocking.  
In the literature, it was found that diabetes alone is associated with 75% increased risk of 
gallstone cancer (Gu, Yan, Wang, Shen, Cao, Fan, & Wang, 2016). Gu et. al. also report that 
having gallstone disease may predict the development of diabetes. With the close correlation 
between the two, it is suggested that patients with either diabetes or gallbladder disease be 
monitored for gallbladder cancer as well. More research is needed to clarify the correlation (Gu 
et. al., 2016).  
 Due to the high incidence of gallbladder disease in patients with diabetes, it is imperative 
to know if medications can have a causative effect also. This conclusion was, in fact, proven in a 
study that correlates an increased risk of gallbladder disease when using incretin-based drugs, 
specifically the GLP-1 analogues (exenatide and liraglutide) in the management of diabetes. The 
rapid weight loss effect of this class of medications is thought to be the correlation to the 
increased risk of gallbladder disease. Rapid weight loss causes supersaturation of cholesterol in 
the bile duct, leading to the formation of gallstones (Faillie, Yu, Hui Yin, Hillaire-Buys, Barkun, 
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Azoulay, & Yin, 2016). Patients having a diagnosis of diabetes increases the risk of the 
development of gallbladder disease. Managing patients’ medication and the possible side effects 
is imperative and should be monitored closely to prevent further complications or development 
of other comorbidities.  
Treatment 
Current guidelines for care of patients with diabetes include a regimen of a statin, beta 
blocker, and aspirin for cardiovascular protective effects due to the comorbidities (American 
Diabetes Association, 2018). Diabetes is commonly seen with hypertension and increased 
cholesterol, which can lead to cardiovascular disease. These guidelines are cardiovascular 
protective and will promote better outcomes for patients.  
Implementation of two or three of the American Heart Association’s Life Simple 7 (a 
physically active lifestyle; healthy diet; healthy BMI; avoiding smoking; and lower blood 
pressure, fasting glucose, and low total cholesterol) was found successful in its study of a group 
of American Indians. It was positively associated with a decrease in diabetes (Fretts et al., 2014). 
As healthcare providers, it is imperative to educate patients about the risk of being overweight, 
living a sedentary lifestyle, using alcohol and tobacco, and consuming an unhealthy diet to 
prevent diabetes and decrease the chance of developing gallbladder disease. 
Conclusion: Learning Points 
 Despite being unable to come to an absolute conclusion to determine a cause and effect 
relationship between diabetes and gallbladder disease in patients of Native American ancestry, it 
is clear that the risk factors for both gallbladder disease and diabetes are the same. It is also clear 
that the correlation between diabetes and gallbladder disease cannot be ignored. With this, it is 
important to aim at prevention, both primary and secondary.  
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The application of prevention strategies will help families develop and live healthier 
lifestyles for parents and children alike. Implementing at least two of the seven American Heart 
Association’s Life’s Simple 7 will also prevent diabetes and a healthy lifestyle (Fretts et al., 
2014). In educating patients on preventative care, healthcare providers can aim to prevent the 
development of both diabetes and gallbladder disease in all patients.   
  Although the following strategies are already known for the prevention of diabetes, these 
can be applied to prevent gallbladder disease as well. 
• Dietary changes: Curb caloric intake, healthy food choices, limit sweetened beverages, 
decrease portion sizes, eat breakfast everyday 
• Limit the amount of times eating takeout food 
• Activity: Increase exercise to at least three times per week 
• Limit screen time 
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